Mizuho

October 09, 2017

PCSK9 wrangle opens can of worms for antibody makers

Regeneron and Sanofi's PCSK9 court win could reverberate across the whole monoclonal antibody space.

October 02, 2017

US open access plan backfires

August 25, 2017

Snippet roundup: Adamas and Alexion score approvals and Amgen gets the price right

August 04, 2017

Upcoming events – FDA decision for Adamas in Parkinson’s dyskinesia and growth data for Versartis

July 21, 2017

Data put a dent in Ironwood’s expansion plans

June 14, 2017

No near-term cure for Repatha and Praluent discontents

March 29, 2017

Roche prices Ocrevus for maximum disruption

March 29, 2017

Roche prices Ocrevus for maximum disruption

March 09, 2017

Event – FDA panel to re-examine Opana ER